Every lot is tried & tested in a relevant biological assay.
Our Bioassay
- Ishikawa, T. et al. (1993) Circ. Res. 73, 1128.
- Sorkin, E.M. and Clissold, S. P. (1987) Drugs 33, 296.
- Furukawa, T. et al. (2005) J. Cardiovasc. Pharmacol. 45, 241.
- Alomone Labs Nicardipine HCl blocks L-type Ca2+ currents in Xenopus oocytes.Superimposed current traces of L-type channels (CaV1.2+α2δ1+β1a), before and during applications of 1, 10 and 100 μM Nicardipine HCl (#N-125) as indicated on the left. Holding potential was -100 mV and currents were elicited every 10 seconds by 100 ms steps to +10 mV.
- Haller, H. (2008) Int. J. Clin. Practice 62, 781.
- Hockerman, G.H. et al. (1997) Ann. Rev. Pharmacol. Toxicol. 37, 361.
- Ishikawa, T. et al. (1993) Circ. Res. 73, 1128.
- Sorkin, E.M. and Clissold, S. P. (1987) Drugs 33, 296.
- Furukawa, T. et al. (2005) J. Cardiovasc. Pharmacol. 45, 241.
- Quignard, J.F. et al. (1997) J. Clin. Invest. 99, 185.
- Goto, K. et al. (1989) Proc. Natl. Acad. Sci. U.S.A. 86, 3915.
L-type (CaV1), voltage-gated Ca2+ channels are plasma membrane protein complexes which allow the passage of Ca2+ ions into cells following depolarization of the membrane potential. L-type channels are widely expressed in cardiac and smooth muscle in which they control contraction and therefore were recognized as a therapeutic target for cardiovascular diseases1,2. Dihydropyridines (DHP) are molecules that act as allosteric modulators of L-type channels and many are used in the clinic to treat hypertension2.
Nicardipine HCl is a dihydropyridine that acts as L-type, voltage-gated Ca2+ channel blocker and is used in the clinic to treat hypertension3,4. Nicardipine inhibits L- and T-type CaV channels with similar potency5. In human coronary myocytes, nicardipine inhibited the Ca2+ currents with an IC50 of ~2 µM6, While in porcine coronary artery strips 2 nM nicardipine were effective in inhibiting the constrictive response to of this muscle to endothelin7.
Nicardipine HCl (#N-125) is a highly pure, synthetic, and biologically active compound.
Applications
Specifications
Scientific Background
Citations
Related Products
- (R)(+)-Bay K8644 (#B-352)
- Benidipine hydrochloride (#B-120)
- L-651,582 (#L-110)
- L-Ascorbic acid (#L-140)
- Anti-CaV1.1 (CACNA1S) (extracellular) Antibody (#ACC-314)
- Anti-CaV1.2 (CACNA1C) Antibody (#ACC-003)
- Anti-CaV1.3 (CACNA1D) Antibody (#ACC-005)
- Anti-CACNA1G (CaV3.1) Antibody (#ACC-021)
- Anti-CaV3.2 (CACNA1H) Antibody (#ACC-025)
- Anti-CaV3.3 (CACNA1I) Antibody (#ACC-009)
- L-Type CaV Channel Blocker Explorer Kit (#EK-103)
- T-Type CaV Channel Blocker Explorer Kit (#EK-111)
- L-Type CaV Channel Antibody Explorer Kit (#AK-215)
- Non-L-Type CaV Channel Antibody Explorer Kit (#AK-216)
- CaV1.2 (CACNA1C) Channel Basic Research Pack (#ESB-100)
- CaV1.2 (CACNA1C) Channel Premium Research Pack (#ESP-100)
- CaV1.2 (CACNA1C) Channel Deluxe Research Pack (#ESD-100)
- T-Type CaV Channel Basic Research Pack (#ESB-101)
- T-Type CaV Channel Premium Research Pack (#ESP-101)
- T-Type CaV Channel Deluxe Research Pack (#ESD-101)
Need Help With This Product?
Our reagent specialists are here to help you find the best product for your application. Please call or email us and we will be happy to help you find the right product for the job.
Call us at
+972 2587 2202 or Email Us